Glucotrack, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-18. Between them they name 2 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Departing: Paul V. Goode
On September 14, 2026, Paul V. Goode notified the Board of Directors of Glucotrack, Inc. (the "Company") of his resignation from the Board, effective immediately.
Appointed: Erik Emerson
On July 9, 2026, the Acquiror Board expanded the size of the Board from five (5) members to six (6) members, effective upon the Closing, and appointed Erik Emerson to fill the vacancy created by such expansion, effective upon the Closing.
Appointed: Erik Emerson, Chief Executive Officer
Mr. Emerson was appointed Chief Executive Officer of Lokahi Therapeutics Inc. in December 2025.
Find people with the same kind of experience as the Chief Executive Officer at Glucotrack, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Glucotrack, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Glucotrack, Inc. is in the news or changes leadership.
Get an alert when Glucotrack, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Glucotrack, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.